Distler, Oliver; Brown, Kevin K; Distler, Jörg H W; Assassi, Shervin; Maher, Toby M; Cottin, Vincent; Varga, John; Coeck, Carl; Gahlemann, Martina; Sauter, Wiebke; Schmidt, Hendrik; Highland, Kristin B; SENSCIS™ trial investigators (2017). Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™). Clinical and Experimental Rheumatology, 35 Suppl(4):75-81.
Additional indexing
Item Type: | Journal Article, refereed, original work |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Rheumatology Clinic and Institute of Physical Medicine |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Health Sciences > Rheumatology
Health Sciences > Immunology and Allergy Life Sciences > Immunology |
Language: | English |
Date: | 29 June 2017 |
Deposited On: | 11 Jul 2017 14:51 |
Last Modified: | 21 Nov 2023 08:08 |
Publisher: | Pacini Editore SpA |
ISSN: | 0392-856X |
OA Status: | Closed |
PubMed ID: | 28664834 |
Users (please log in): Suggest update or correction for this item
For submitters/editors: Edit metadata
Download
Authors, Affiliations, Collaborations

UniversitatsSpital Zurich, Zurich, Switzerland
Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
University of Texas Medical School at Houston, Houston, United States
Royal Brompton Hospital, London, United Kingdom
National Heart and Lung Institute, London, United Kingdom
National Heart and Lung Institute, London, United Kingdom
Université Claude Bernard Lyon 1, Villeurbanne, France
Northwestern University Feinberg School of Medicine, Chicago, United States
Boehringer Ingelheim, Brussels, Belgium
Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
Cleveland Clinic Foundation, Cleveland, United States